Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K M Debatin

Showing results (41-50 of 239) with videos related to

Pageof 24
Sort By:
Klinische Padiatrie|January 1, 1987
[Local recurrence of mediastinal non-Hodgkin lymphomas in childhood]R Ludwig, K M Debatin, W E Brandeis
European Journal of Immunology|March 1, 1994
Differential expression of APO-1 on human thymocytes: implications for negative selection?K M Debatin, D Süss, P H Krammer
Molecular Pathology : MP|March 14, 1998
Whole genome amplification of single cells from clinical peripheral blood smearsC P Beltinger, F Klimek, K M Debatin
Agents and Actions|December 1, 1981
Depressed mediator release by inflammatory exudate cells in immunized rats following antigen challengeK M Debatin, H G Leser, H Northoff
Leukemia|March 23, 1999
Chemotherapeutic drugs sensitize pre-B ALL cells for CD95- and cytotoxic T-lymphocyte-mediated apoptosisC Posovszky, C Friesen, I Herr, et al.
Leukemia|November 1, 1996
Activation of T cell cytotoxicity against autologous common acute lymphoblastic leukemia (cALL) blasts by CD3xCD19 bispecific antibodyM Csóka, G Strauss, K M Debatin, et al.
European Journal of Immunology|March 4, 1998
TRAIL/Apo-2-ligand-induced apoptosis in human T cellsI Jeremias, I Herr, T Boehler, et al.
Oncogene|October 18, 2006
Role of hypoxia inducible factor-1 alpha in modulation of apoptosis resistanceM Kilic, H Kasperczyk, S Fulda, et al.
Klinische Padiatrie|September 3, 1999
Betulinic acid: a new chemotherapeutic agent in the treatment of neuroectodermal tumorsS Fulda, I Jeremias, T Pietsch, et al.
Cell Death and Differentiation|June 17, 2000
mAb33 from transduction laboratories specifically binds human CD95-LI Herr, C Posovsky, T Böhler, et al.
Pageof 24

Showing results (41-50 of 239) with videos related to

Sort By:
Pageof 24
Klinische Padiatrie|January 1, 1987
[Local recurrence of mediastinal non-Hodgkin lymphomas in childhood]R Ludwig, K M Debatin, W E Brandeis
European Journal of Immunology|March 1, 1994
Differential expression of APO-1 on human thymocytes: implications for negative selection?K M Debatin, D Süss, P H Krammer
Molecular Pathology : MP|March 14, 1998
Whole genome amplification of single cells from clinical peripheral blood smearsC P Beltinger, F Klimek, K M Debatin
Agents and Actions|December 1, 1981
Depressed mediator release by inflammatory exudate cells in immunized rats following antigen challengeK M Debatin, H G Leser, H Northoff
Leukemia|March 23, 1999
Chemotherapeutic drugs sensitize pre-B ALL cells for CD95- and cytotoxic T-lymphocyte-mediated apoptosisC Posovszky, C Friesen, I Herr, et al.
Leukemia|November 1, 1996
Activation of T cell cytotoxicity against autologous common acute lymphoblastic leukemia (cALL) blasts by CD3xCD19 bispecific antibodyM Csóka, G Strauss, K M Debatin, et al.
European Journal of Immunology|March 4, 1998
TRAIL/Apo-2-ligand-induced apoptosis in human T cellsI Jeremias, I Herr, T Boehler, et al.
Oncogene|October 18, 2006
Role of hypoxia inducible factor-1 alpha in modulation of apoptosis resistanceM Kilic, H Kasperczyk, S Fulda, et al.
Klinische Padiatrie|September 3, 1999
Betulinic acid: a new chemotherapeutic agent in the treatment of neuroectodermal tumorsS Fulda, I Jeremias, T Pietsch, et al.
Cell Death and Differentiation|June 17, 2000
mAb33 from transduction laboratories specifically binds human CD95-LI Herr, C Posovsky, T Böhler, et al.
Pageof 24